CutisPharma Appoints Steven Dinh As Chief Scientific Officer

PR Newswire (press release)-6 hours ago

"CutisPharma has been a leading developer of innovative products for the pharmacy compoundingmarket and I am pleased to lead the Company's transition ..

Imprimis Pharmaceuticals to Host its Second Quarter 2016 Financial ...

PR Newswire (press release)-3 hours ago

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) is a pharmaceutical company dedicated to making drugs affordable again through its Branded Compounding™ ..

A number of U.S. Olympians are endorsing dietary supplements that haven't been shown to work, Rebecca Robbins reports at STAT.

Rumors of disinterest in animal health aside, Merck and Bayer shine in Q2